63 / 490
SATURDAY 30 APRIL 2016
61
SCIENTIFIC PROGRAMME
| PROGRAMME AND EXHIBITION GUIDE
08:45 > The axilla- less surgery, more radiotherapy?
Speaker: M.I. Algara López (Spain)
SP-0015
09:10 > The internal mammary chain - should we treat it in every
node-positive patient?
Speaker: P. Poortmans (The Netherlands)
SP-0016
09:35 > Technical approaches to regional lymph node irradiation
for breast cancer
Speaker: A. Kirby (UK)
SP-0017
Symposium
ASSESSMENT ANDMANAGEMENT OF RECTAL MORBIDITY
08:45 - 10:00 | GIALLA
This symposium is dedicated to clarifying the rectal symptoms after radiotherapy to the small pel-
vis. Only a few are directly linked to ionizing radiation to the bowel or anal sphincter region. It will
be discussed the definition of unique set of pathophysiology to be introduced in the planning of ra-
diotherapy. The second topic will aim to distinguish between objective toxicity scoring and subjec-
tive patient reported outcomes. Rectal and anal toxicity dose volume histogram and changes will be
discriminated. Lastly, the impact and the interest of using rectal spacer to minimized morbidity during
irradiation of prostate cancer will be commented.
Chair: P. Maingon (France)
Co-Chair: D. Genovesi (Italy)
08:45 > Towards a scoring system built on six distinct radiation-induced illnesses
producing late gastrointestinal effects
Speaker: G. Steineck (Sweden)
SP-0018
09:10 > Measuring anorectal toxicity and function
Speaker: D. Vordermark (Germany)
SP-0019
09:35 > Rectal spacers to minimise morbidity in radiotherapy for prostate cancer
Speaker: M. Pinkawa (Germany)
SP-0020